Agents | Brand names | Dosing |
Combination long-acting muscarinic antagonist/long-acting beta agonist inhalers | ||
Aclidinium 400 mcg/formoterol 12 mcg | Duaklir Genuair (Canada) Duaklir Pressair (United States) | 1 inhalation twice daily; DPI |
Glycopyrrolate 50 mcg/indacaterol 110 mcg* | Ultibro Breezhaler (Canada) | 1 capsule (inhalation only), once daily; DPI |
Glycopyrrolate 9 mcg/formoterol 4.8 mcg | Bevespi Aerosphere (United States) | 2 inhalations twice daily; pMDI |
Tiotropium 2.5 mcg/olodaterol 2.5 mcg per actuation | Stiolto Respimat (United States) Inspiolto Respimat (Canada) | 2 inhalations once daily; SMI |
Umeclidinium 62.5 mcg/vilanterol 25 mcg | Anoro Ellipta (United States and Canada) | 1 inhalation once daily; DPI |
Triple combination glucocorticoid/long-acting muscarinic antagonist/long-acting beta agonist inhaler | ||
Fluticasone furoate 100 mcg/umeclidinium 62.5 mcg/vilanterol 25 mcg | Trelegy Ellipta (United States) | 1 inhalation once daily; DPI |
Budesonide 160 mcg/glycopyrrolate 9 mcg/4.8 mcg formoterol | Breztri Aerosphere (United States and Canada) | 2 inhalations twice daily; MDI |
Do you want to add Medilib to your home screen?